<div id="readability-page-1"><div><h2>Recent share performance and what it might signal</h2> <p>Home BancShares (HOMB) has traded around US$26.84 recently, with the stock effectively flat over the past week and month, and slightly down over the past 3 months and year to date.</p> <p>Over a 1 year period, total return has been slightly negative, while the 3 year and 5 year total returns are positive. This gives you a mixed picture of shorter term softness alongside longer term gains.</p> <p>See our latest analysis for Home BancShares.</p> <p>Recent trading has been relatively subdued, with a 1-day share price return of 2.64% at US$26.84, alongside a year to date share price decline of 3.83% and a 3-year total shareholder return of 23.28%. This points to fading short term momentum together with still constructive longer term results.</p> <p>If this kind of mixed banking performance has you thinking about where else capital could work, it may be worth scanning 21 top founder-led companies</p> <p>With Home BancShares trading around US$26.84 and indicators suggesting a possible discount to some valuation estimates, the key question for you is simple: is there a genuine opportunity here, or is the market already pricing in future growth?</p> <h2>Most Popular Narrative: 14.2% Undervalued</h2> <p>Analysts following Home BancShares see fair value at about $31.29 per share, compared with the recent $26.84 price, which puts their narrative in focus.</p> <blockquote> <p><em>The company's strong presence and loan growth in high-growth markets such as Texas, Florida, and Arkansas positions it to capture outsized revenue and deposit growth as economic and population expansion in these Sun Belt states continues, supporting sustained top-line growth.</em></p> </blockquote> <p><em>Read the complete narrative.</em> Read the complete narrative.</p> <p>Analysts are effectively tying this valuation to a specific playbook. It hinges on steady revenue expansion, firm profit margins, and a future earnings multiple that nudges above the wider US bank group. The full narrative spells out how those assumptions fit together and what needs to go right for that fair value to hold.</p> <p><strong>Result: Fair Value of $31.29 (UNDERVALUED)</strong></p> <p>Have a read of the narrative in full and understand what's behind the forecasts.</p> <p>However, you also need to weigh the heavier reliance on acquisitions and the concentrated loan exposure in specific markets, which could quickly weaken margins if conditions turn.</p> <p>Find out about the key risks to this Home BancShares narrative.</p> <h2>Another View On Valuation</h2> <p>The analyst narrative leans on a fair value of about $31.29 per share, but the P/E picture is more cautious. Home BancShares trades on roughly 11.3x earnings, slightly above the peer average at 11x and just above an estimated fair ratio of 11.2x. This combination hints at limited room for error if the story softens.</p> <p>If you prefer to anchor decisions on what current earnings multiples imply, rather than analyst targets alone, the See what the numbers say about this price — find out in our valuation breakdown.</p> <figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/d90a19d7-eb6f-4bbf-8bbc-1aca37118e66/chart/pe-multiple-vs-industry/query-ZGF0ZT0yMDI2LTA2LTA1?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/d90a19d7-eb6f-4bbf-8bbc-1aca37118e66/chart/pe-multiple-vs-industry/query-ZGF0ZT0yMDI2LTA2LTA1"/><figcaption>NYSE:HOMB P/E Ratio as at Jun 2026</figcaption></figure><h2>Next Steps</h2> <p>With the story so mixed, it makes sense to look past the headlines and weigh the details yourself while sentiment is still forming. To see why some investors are focusing on the upside, take a closer look at the 4 key rewards</p> <h2>Ready to hunt for more investment ideas?</h2> <p>Do not stop with one stock when there are clear lists of opportunities you can scan in minutes, or you risk missing ideas that better fit your goals.</p> <ul> <li>Target resilient income by scanning 10 dividend fortresses that may suit a portfolio focused on regular cash returns.</li> <li>Angle for value by reviewing screener containing 22 high quality undiscovered gems built on strong fundamentals that the market might be overlooking.</li> <li>Prioritise stability by checking 65 resilient stocks with low risk scores that score well on Simply Wall Street's risk framework.</li> </ul> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data         and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your         financial situation. We aim to bring you long-term focused analysis driven by fundamental data.         Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.         Simply Wall St has no position in any stocks mentioned.</em></p><div><h3>Valuation is complex, but we're here to simplify it.</h3><p>Discover if Home BancShares might be undervalued or overvalued with our detailed analysis, featuring <strong>fair value estimates, potential risks, dividends, insider trades, and its financial condition.</strong></p><p>Access Free Analysis</p></div></div></div>

HOMB

<p>Home BancShares (HOMB) shares trade around $26.84, showing flat short-term performance but positive long-term returns. Analysts estimate a fair value of $31.29, suggesting the stock is undervalued by approximately 14.2%, driven by growth in Texas, Florida, and Arkansas. However, the P/E ratio of 11.3x is slightly above peer averages, indicating limited margin for error. Key risks include reliance on acquisitions and concentrated loan exposure.</p>

A Look At Home BancShares (HOMB) Valuation As Shares Trade Sideways And Analyst Targets Differ